HAEMONETICS CORP (HAE) › Operating Cash FlowHAEMONETICS CORP (HAE) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: $116.36M2010: $130.67M2011: $123.45M2012: $115.32M2013: $85.07M2014: $139.52M2015: $127.18M2016: $121.86M2017: $159.74M2018: $220.35M2019: $159.28M2020: $158.22M2021: $108.81M2022: $172.26M2023: $273.06M2024: $181.75M2025: $181.72M2026: $293.22M$293.22M2009Operating Cash Flow (USD)2026Fiscal YearOperating Cash FlowChange YoY2026$293.22M+61.4%2025$181.72M-0.0%2024$181.75M-33.4%2023$273.06M+58.5%2022$172.26M+58.3%2021$108.81M-31.2%2020$158.22M-0.7%2019$159.28M-27.7%2018$220.35M+37.9%2017$159.74M+31.1%2016$121.86M-4.2%2015$127.18M-8.8%2014$139.52M+64.0%2013$85.07M-26.2%2012$115.32M-6.6%2011$123.45M-5.5%2010$130.67M+12.3%2009$116.36M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share